Medical Condition News

RSS

New data from Genzyme's AUBAGIO and LEMTRADA clinical trials to be presented at ECTRIMS

Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.

9 Oct 2012

Central Baptist receives ACTION Registry–GWTG Platinum Performance Achievement Award

Central Baptist Hospital is one of only 164 hospitals nationwide to receive the American College of Cardiology Foundation's NCDR ACTION Registry–Get With The Guidelines Platinum Performance Achievement Award for 2012.

9 Oct 2012

Scripps scientists to study several compounds with potential to improve QOL for ALS patients

A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.

9 Oct 2012

Study sheds light on fundamental cellular process

Scientists at the Gladstone Institutes have mapped the precise frequency by which genes get turned on across the human genome, providing new insight into the most fundamental of cellular processes-and revealing new clues as to what happens when this process goes awry.

9 Oct 2012

Group-based behavioral weight loss treatment effective in treating obesity

A new National Institutes of Health (NIH)-funded study conducted at Baruch College and published in Obesity found that overweight and obese adults who participated in three different weight loss treatments, all involving intensive, multi-component counseling delivered in groups, lost significant weight after 48 weeks whether the treatment was led by a health professional or by someone who had previous weight loss success.

9 Oct 2012

BDNF deletion plays a critical role in psychiatric disease and obesity

McGill researchers have identified a small region in the genome that conclusively plays a role in the development of psychiatric disease and obesity. The key lies in the genomic deletion of brain-derived neurotrophic factor, or BDNF, a nervous system growth factor that plays a critical role in brain development.

9 Oct 2012

Scientists discover how protein deficiency may be linked to frontotemporal dementia

Using animal models, scientists at the Gladstone Institutes have discovered how a protein deficiency may be linked to frontotemporal dementia (FTD)-a form of early-onset dementia that is similar to Alzheimer's disease. These results lay the foundation for therapies that one day may benefit those who suffer from this and related diseases that wreak havoc on the brain.

9 Oct 2012

New blood test can read genetic changes in prostate cancer

Scientists have designed a blood test that reads genetic changes like a barcode - and can pick out aggressive prostate cancers by their particular pattern of gene activity.

9 Oct 2012

Endotrophin may serve as novel therapeutic target for breast cancer

Fat cells (adipocytes) surround breast tumors and contribute to tumor growth by expressing factors that aid oncogenesis. Col6 is a protein that is highly expressed in adipocytes and its expression is further increased in both obesity and in breast cancer cells.

9 Oct 2012

Morphine inhibits BDNF protein, whereas cocaine enhances BDNF

Chronic morphine exposure has the opposite effect on the brain compared to cocaine in mice, providing new insight into the basis of opiate addiction, according to Mount Sinai School of Medicine researchers. They found that a protein called brain-derived neurotrophic factor (BDNF), which is increased in cocaine addiction, is inhibited in opioid addiction. The research is published in the October 5 issue of Science.

8 Oct 2012

Alzheimer's disease diagnosis within minutes using a simple brain scan

Groundbreaking research taking place at the University of York could lead to Alzheimer's disease being diagnosed in minutes using a simple brain scan.

8 Oct 2012

High levels of chronic and acute illnesses in Palestinian refugees

New research draws attention to the continuing and urgent health emergency facing Palestinians living under occupation, especially the health and wellbeing issues surrounding refugees from the occupied Palestinian territories. Abstracts of the research, which were presented at the fourth meeting of The Lancet Palestinian Health Alliance in March 2012, are published online in The Lancet.

8 Oct 2012

New neuroprotective agent for stroke patients potentially found

Scientists have shown that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair a brain aneurysm, compared to placebo, and appears to be safe to use, according to an Article published Online First in The Lancet Neurology.

8 Oct 2012

Run for Healthy Heart attracts over 2,000 participants

In association with the Billion Hearts Beating Foundation, Indraprastha Apollo Hospitals organised a 5-km run titled 'Dil ki Daud'. In the wee hours of Sunday, more than 2,000 people participated in the 5-km run, which kicked off at 6:45 am. India's first blade runner and Kargil War amputee hero Retd. Major Devender Pal Singh - also participated in order to encourage the runners for a healthy living.

8 Oct 2012

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

ImaginAb, Inc., a clinical-stage company developing in vivo molecular imaging agents based on antibody fragment technology, today announced that it has entered into a collaboration and commercialization agreement with H. Lundbeck A/S.

8 Oct 2012

NovaSom launches full-service testing program for pre-operative diagnosis of OSA

NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announces the launch of AccuSom Safe Recovery.

8 Oct 2012

NCI awards Cellerant SBIR contract to develop Megakaryocyte Progenitor Cell therapy for thrombocytopenia

Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 contract and a Phase 2 option from the National Cancer Institute (NCI) valued up to $1,683,503.

8 Oct 2012

Trevena reports completion of TRV027 Phase 2a study in advanced heart failure patients

Trevena, Inc., the leader in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced that it has successfully completed a Phase 2a study on the hemodynamic effects of TRV027 in patients with advanced heart failure with reduced ejection fraction.

8 Oct 2012

Hygieia granted CE mark for d-Nav Diabetes Insulin Guidance System

Hygieia, Inc. today announced that the company's d-Nav Diabetes Insulin Guidance System (DIGS) has been granted a CE mark.

8 Oct 2012

Scientists discover process by which vitamin B12 is made in cells

In a development that may lead to new drugs to treat cancer, scientists at the University of Kent have discovered the process by which a key vitamin (B12) is made in cells.

8 Oct 2012

Medical Condition News

New data from Genzyme's AUBAGIO and LEMTRADA clinical trials to be presented at ECTRIMS

Central Baptist receives ACTION Registry–GWTG Platinum Performance Achievement Award

Scripps scientists to study several compounds with potential to improve QOL for ALS patients

Study sheds light on fundamental cellular process

Group-based behavioral weight loss treatment effective in treating obesity

BDNF deletion plays a critical role in psychiatric disease and obesity

Scientists discover how protein deficiency may be linked to frontotemporal dementia

New blood test can read genetic changes in prostate cancer

Endotrophin may serve as novel therapeutic target for breast cancer

Morphine inhibits BDNF protein, whereas cocaine enhances BDNF

Alzheimer's disease diagnosis within minutes using a simple brain scan

High levels of chronic and acute illnesses in Palestinian refugees

New neuroprotective agent for stroke patients potentially found

Run for Healthy Heart attracts over 2,000 participants

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

NovaSom launches full-service testing program for pre-operative diagnosis of OSA

NCI awards Cellerant SBIR contract to develop Megakaryocyte Progenitor Cell therapy for thrombocytopenia

Trevena reports completion of TRV027 Phase 2a study in advanced heart failure patients

Hygieia granted CE mark for d-Nav Diabetes Insulin Guidance System

Scientists discover process by which vitamin B12 is made in cells

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Latest News